NGVTIngevity Corporation
$69.03+22% 1Y
$69.03
$46.2052 weeks$77.87
Latest close: below its 200-day averageOct 12, 2026what changed →
The financials
Ingevity Corporation by the numbers
Ingevity Corporation (NGVT) reported revenue of $314M in Q2 2026 (quarter ended Jun 30, 2026), down 5.2% from the same quarter a year earlier. That came with a gross margin of 44% and net income of $35M (11% of revenue). For the full year FY2025, revenue was $1.17B (−2.7% year on year) and net income −$167M. Its largest region in Q2 2026 was North America at $178M, 67% of the disclosed total, well ahead of Asia Pacific at 29%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $314M | $332M | −5.2% |
| Gross profit | $139M | $128M | +8.8% |
| Net income | $35M | −$147M | to a profit |
| Diluted EPS | $1.00 | −$4.02 | to a profit |
| Geographic | Revenue | Share |
|---|---|---|
| North America | $178M | 67% |
| Asia Pacific | $77M | 29% |
| South America | $11M | 4.3% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $266.8M (+25%)
Asia Pacific grew +3.6% year on yearNorth America -11% year on year
Segment Latestquarter on quarteryear on year
- North America$178.0M$178.0Mquarter on quarter +38%year on year -11%+38%-11%
- Asia Pacific$77.4M$77.4Mquarter on quarter +6.6%year on year +3.6%+6.6%+3.6%
- South America$11.4M$11.4Mquarter on quarter -5.8%year on year -0.87%-5.8%-0.87%
Specialty Chemicals
Ranks #5 of 33 by RyuScore